Article | June 28, 2024

How DFM Promotes Scalability, Repeatability, And Profitability

Source: SMC Ltd.
GettyImages-1294339649 drug development, cleanroom

DFM discussion must be concise and backed by both historical data and up-to-the-minute insights, e.g., discovered through prototyping, test runs, etc. It is critical that OEMs see and understand the benefits of taking time to build a mold or create automation more robustly because, although time is being lost up front, long-term savings and higher annual volume production can be realized.

This article explores a case study in which device design changes and tweaks to the production process enabled SMC to deliver high production volumes — the project covered 14 different SKUs comprising four million units annually — while simultaneously offering design and engineering suggestions to minimize the likelihood of quality issues and to lower cost, combining goals that typically do not align well.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Med Device Online? Subscribe today.

Subscribe to Med Device Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Med Device Online